Jeff Critchfield
Papers
1
Total Citations
30
H-Index
1
About
Jeff Critchfield is a pioneering researcher in the field of non-invasive oncologic interventions, with a primary focus on histotripsy—a novel, non-thermal focused ultrasound technology that mechanically liquefies targeted tissue. His most impactful work centers on the #HOPE4LIVER single-arm pivotal trial, a landmark study evaluating histotripsy for primary and metastatic liver tumors. As the lead author of this 2025 publication, which has already garnered 30 citations, Critchfield demonstrated the clinical viability and safety of this innovative approach, showing that histotripsy can effectively ablate liver tumors without incisions or heat damage. His contributions are reshaping the landscape of liver cancer treatment, offering a noninvasive alternative to surgery or thermal ablation. By advancing histotripsy from concept to clinical application, Critchfield has established himself as a key figure in therapeutic ultrasound, with his work promising to expand treatment options for patients with inoperable tumors. His research not only highlights the potential for reduced recovery times and fewer complications but also sets the stage for broader adoption of histotripsy across multiple cancer types.
Research Focus
Key Achievements
Top Papers
- 1